St. Clair Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414K Hold
4,000
0.11% 68
2026
Q1
$287K Sell
4,000
-2,022
-34% -$156K 0.08% 75
2025
Q4
$478K Hold
6,022
0.12% 67
2025
Q3
$454K Buy
6,022
+22
+0.4% +$1.51K 0.12% 69
2025
Q2
$414K Hold
6,000
0.11% 67
2025
Q1
$407K Hold
6,000
0.11% 67
2024
Q4
$269K Sell
6,000
-7,554
-56% -$424K 0.08% 73
2024
Q3
$852K Hold
13,554
0.24% 49
2024
Q2
$800K Hold
13,554
0.26% 49
2024
Q1
$1.08M Buy
13,554
+710
+6% +$54.2K 0.35% 42
2023
Q4
$1.01M Buy
12,844
+617
+5% +$43.9K 0.35% 45
2023
Q3
$854K Hold
12,227
0.34% 42
2023
Q2
$845K Buy
12,227
+554
+5% +$39.4K 0.33% 43
2023
Q1
$867K Buy
11,673
+7,205
+161% +$604K 0.38% 41
2022
Q4
$416K Buy
+4,468
New +$431K 0.26% 37

Other funds holding CVS

St. Clair Advisors's CVS Position: Q2 2026 in Review

St. Clair Advisors held its CVS Health (CVS) position steady in Q2 2026 at 4,000 shares worth $414K. The position accounts for 0.11% of the portfolio, ranked #68.

St. Clair Advisors first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.08M in Q1 2024. 505 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • St. Clair Advisors held 4,000 shares of CVS Health worth $414K as of Q2 2026.
  • St. Clair Advisors left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.11% of St. Clair Advisors's portfolio in Q2 2026, its #68 holding.
  • St. Clair Advisors first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • St. Clair Advisors's CVS Health position peaked at $1.08M in Q1 2024.
  • 505 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on St. Clair Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.